Lv3
384 积分 2022-03-14 加入
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
2天前
已完结
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3
2天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
11天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
18天前
已完结
Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy
23天前
已完结
Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy
24天前
已完结
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study
24天前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
29天前
已完结
B cells are associated with survival and immunotherapy response in sarcoma
2个月前
已完结
The present and future of bispecific antibodies for cancer therapy
2个月前
已完结
皖公网安备34019202002308
